-+ 0.00%
-+ 0.00%
-+ 0.00%

J&J - TECVAYLI PLUS DARZALEX FASPRO REDUCES MULTIPLE MYELOMA PROGRESSION RISK BY 90% VERSUS STANDARD OF CARE

Reuters·09/23/2026 13:50:04